Cyclis Pharmaceuticals

Cyclis Pharmaceuticals focuses on the discovery and development of novel small molecule drugs aimed at correcting common cell checkpoint and apoptosis defects in cancer cells through activated checkpoint therapy, enabling customers to achieve higher efficacy and lower toxicity compared to traditional cancer treatments.